Compare Stocks: LEXX, PYRGF, BGM, and ABVC

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABVC ABVC BioPharma	$0.95 -6.9%	$1.34	$0.88 ▼ $3.40	$25.23M	0.57	103,973 shs	174,958 shs
BGM BGM Group	$0.30 -0.1%	$0.33	$0.25 ▼ $11.80	$29.17M	1.8	291,558 shs	23,221 shs
LEXX Lexaria Bioscience	$5.49 +4.2%	$8.32	$4.21 ▼ $23.25	$9.06M	0.38	11,783 shs	9,562 shs
PYRGF PyroGenesis Canada	$0.16 +7.5%	$0.15	$0.12 ▼ $0.53	$35.74M	0.27	53,547 shs	58,143 shs

7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABVC ABVC BioPharma	0.00%	+0.99%	-32.45%	0.00%	-62.22%
BGM BGM Group	0.00%	+6.52%	-10.33%	+14.13%	-96.10%
LEXX Lexaria Bioscience	0.00%	-10.14%	-45.66%	-41.91%	-58.42%
PYRGF PyroGenesis Canada	0.00%	+15.91%	-3.16%	-53.33%	-47.43%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABVC ABVC BioPharma	$0.95 -6.9%	$1.34	$0.88 ▼ $3.40	$25.23M	0.57	103,973 shs	174,958 shs
BGM BGM Group	$0.30 -0.1%	$0.33	$0.25 ▼ $11.80	$29.17M	1.8	291,558 shs	23,221 shs
LEXX Lexaria Bioscience	$5.49 +4.2%	$8.32	$4.21 ▼ $23.25	$9.06M	0.38	11,783 shs	9,562 shs
PYRGF PyroGenesis Canada	$0.16 +7.5%	$0.15	$0.12 ▼ $0.53	$35.74M	0.27	53,547 shs	58,143 shs

7 Energy Stocks to Buy and Hold Forever

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABVC ABVC BioPharma	0.00%	+0.99%	-32.45%	0.00%	-62.22%
BGM BGM Group	0.00%	+6.52%	-10.33%	+14.13%	-96.10%
LEXX Lexaria Bioscience	0.00%	-10.14%	-45.66%	-41.91%	-58.42%
PYRGF PyroGenesis Canada	0.00%	+15.91%	-3.16%	-53.33%	-47.43%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ABVC ABVC BioPharma	1.00	Sell	N/A	N/A
BGM BGM Group	1.00	Sell	N/A	N/A
LEXX Lexaria Bioscience	2.00	Hold	$22.50	309.84% Upside
PYRGF PyroGenesis Canada	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest LEXX, PYRGF, BGM, and ABVC Analyst Ratings

Date	Company	Brokerage	Action	Rating
8/6/2026	BGM BGM Group	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D) ➝ Sell (E+)
7/24/2026	LEXX Lexaria Bioscience	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
7/13/2026	LEXX Lexaria Bioscience	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
6/25/2026	LEXX Lexaria Bioscience	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
6/15/2026	ABVC ABVC BioPharma	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
5/29/2026	ABVC ABVC BioPharma	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
5/15/2026	ABVC ABVC BioPharma	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)

(Data available from 8/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ABVC ABVC BioPharma	$510K	49.46	N/A	N/A	$0.52 per share	1.83
BGM BGM Group	$37.92M	0.77	N/A	N/A	$4.03 per share	0.07
LEXX Lexaria Bioscience	$710K	12.76	N/A	N/A	$2.00 per share	2.75
PYRGF PyroGenesis Canada	$9.14M	3.91	N/A	N/A	($0.01) per share	-15.82

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ABVC ABVC BioPharma	-$7.91M	-$0.40	N/A	N/A	N/A	N/A	-62.46%	-39.99%	8/18/2026 (Estimated)
BGM BGM Group	-$19.94M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
LEXX Lexaria Bioscience	-$11.90M	-$5.10	N/A	N/A	N/A	N/A	-174.93%	-143.89%	10/28/2026 (Estimated)
PYRGF PyroGenesis Canada	-$21.12M	-$0.04	N/A	N/A	N/A	-115.14%	N/A	-60.81%	N/A

Latest LEXX, PYRGF, BGM, and ABVC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/18/2026	Q2 2026	ABVC ABVC BioPharma	-$0.40	N/A	N/A	N/A	$0.11 million	N/A
7/21/2026	Q4 2025	BGM BGM Group	N/A	-$0.0750	N/A	-$0.0750	N/A	$11.80 million
7/13/2026	Q3 2026	LEXX Lexaria Bioscience	-$0.06	-$0.08	-$0.02	-$1.20	$0.05 million	N/A
5/18/2026	Q1 2026	ABVC ABVC BioPharma	N/A	-$0.06	N/A	-$0.06	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ABVC ABVC BioPharma	N/A	N/A	N/A	N/A	N/A
BGM BGM Group	N/A	N/A	N/A	N/A	N/A
LEXX Lexaria Bioscience	N/A	N/A	N/A	N/A	N/A
PYRGF PyroGenesis Canada	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ABVC ABVC BioPharma	N/A	0.12	0.12
BGM BGM Group	N/A	N/A	N/A
LEXX Lexaria Bioscience	N/A	10.61	10.61
PYRGF PyroGenesis Canada	N/A	0.60	0.50

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ABVC ABVC BioPharma	11.38%
BGM BGM Group	N/A
LEXX Lexaria Bioscience	13.06%
PYRGF PyroGenesis Canada	0.03%

Insider Ownership

Company	Insider Ownership
ABVC ABVC BioPharma	19.00%
BGM BGM Group	58.66%
LEXX Lexaria Bioscience	8.39%
PYRGF PyroGenesis Canada	47.68%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ABVC ABVC BioPharma	30	26.55 million	21.51 million	Not Optionable
BGM BGM Group	298	97.22 million	40.19 million	N/A
LEXX Lexaria Bioscience	7	1.65 million	1.51 million	Not Optionable
PYRGF PyroGenesis Canada	90	225.89 million	96.34 million	No Data

LEXX, PYRGF, BGM, and ABVC Headlines

Recent News About These Companies

PyroGenesis Schedules 2026 Second Quarter Financial Results and Business Update Conference Call

July 31, 2026 | globenewswire.com

PyroGenesis Reports Voting Results From 2026 Meeting of Shareholders

June 23, 2026 | globenewswire.com

PyroGenesis Delivers New Technology to Convert Contaminated Biomass to Syngas

June 17, 2026 | globenewswire.com

P. Peter Pascali Updates Early Warning Report

June 8, 2026 | globenewswire.com

PyroGenesis Announces Closing of $2 Million Private Placement

June 4, 2026 | globenewswire.com

PyroGenesis Announces Closing of $6.26 Million in Financings

June 3, 2026 | globenewswire.com

PyroGenesis Announces Upsize of Bought Deal LIFE Offering to $3.7 Million

May 20, 2026 | globenewswire.com

PyroGenesis Announces $3.0 Million Bought Deal LIFE Offering and Concurrent CEO Private Placement of up to $2.0 Million

May 19, 2026 | newsfilecorp.comN

PyroGenesis Announces a Binding Signed Contract to Acquire its Turcot Manufacturing Facility

May 14, 2026 | globenewswire.com

PyroGenesis Announces First Quarter 2026 Results: Revenue of $4.9 Million, Up 63% ...

May 7, 2026 | caledonianrecord.comC

PyroGenesis Announces First Quarter 2026 Results: Revenue of $4.9 Million, Up 63% Year-Over-Year for Best Quarter Since 2022

May 7, 2026 | globenewswire.com

PyroGenesis Schedules 2026 First Quarter Financial Results and Business Update Conference Call

May 1, 2026 | globenewswire.com

PyroGenesis Provides Corporate Update on NexGen™ Titanium Metal Powder Strategy

April 29, 2026 | globenewswire.com

PyroGenesis Announces Appointment of Jean Mayer as Vice-President, Legal Affairs and Corporate Secretary

April 28, 2026 | globenewswire.com

PyroGenesis Produces Battery-Grade Graphite from Carbon Black Using Proprietary Plasma System

April 23, 2026 | globenewswire.com

PyroGenesis Announces Fourth Quarter and Full Year 2025 Results

March 30, 2026 | globenewswire.com

PyroGenesis Announces Closing of Non-Brokered Private Placement

March 26, 2026 | globenewswire.com

PyroGenesis Schedules 2025 Fiscal Year Financial Results and Business Update Conference Call

March 23, 2026 | globenewswire.com

PyroGenesis Announces Oversubscription of Non-Brokered Private Placement

March 11, 2026 | globenewswire.com

PyroGenesis Announces $1 Million Non-Brokered Private Placement

March 9, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

LEXX, PYRGF, BGM, and ABVC Company Descriptions

ABVC BioPharma NASDAQ:ABVC

$0.95 -0.07 (-6.85%)

As of 04:00 PM Eastern

ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1703, which is in Phase II clinical trials for the treatment of metastatic pancreatic cancer; ABV-1702, which is in Phase II clinical trials to treat myelodysplastic syndromes; and ABV-1601 that is in Phase I/II clinical trials for treating depression in cancer patients. It is also developing ABV-1701 Vitargus that is in Phase II clinical trials for the treatment of retinal detachment or vitreous hemorrhage; and ABV-1519, which is in Phase I/II clinical trials for the treatment of non-small cell lung cancer. ABVC BioPharma, Inc. has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California. ABVC BioPharma, Inc. operates as a subsidiary of YuanGene Corporation.

BGM Group NASDAQ:BGM

$0.30 0.00 (-0.13%)

As of 03:51 PM Eastern

Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions. It offers Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications. In addition, the company offers TCMD products, such as Ahan antibacterial paste to treat refractory chronic skin diseases; heparin products, including heparin sodium preparations for pharmaceutical companies to produce medications for cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and Zhu Xiaochang sausage casings, which are natural food products for culinary application. Further, it provides Xiongguan organic fertilizers to improve crop yield and soil's chemical properties and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers to increased plant growth. Qilian International Holding Group Limited was incorporated in 2019 and is based in Jiuquan, the People's Republic of China.

Lexaria Bioscience NASDAQ:LEXX

$5.49 +0.22 (+4.17%)

As of 04:00 PM Eastern

Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods. The company's DehydraTECH is used with a range of active molecules encompassing fat-soluble vitamins, pain medications, hormones, PDE5 inhibitors, antivirals, oral nicotine and its analogs, and cannabinoids. Its DehydraTECH technology evaluates therapeutic indications, including hypertension, heart disease, and diabetes; and is suitable for a variety of product formats, such as pharmaceuticals, nutraceuticals, over the counter, and consumer packaged goods. Lexaria Bioscience Corp. was incorporated in 2004 and is headquartered in Kelowna, Canada.

PyroGenesis Canada NASDAQ:PYRGF

$0.16 +0.01 (+7.47%)

As of 03:45 PM Eastern

PyroGenesis Canada Inc. designs, develops, manufactures, and commercializes plasma processes and solutions worldwide. The company offers DROSRITE, a process for enhancing metal recovery from dross without any hazardous by-products; plasma atomization process that allows produce and sell high purity spherical metal powders; PUREVAP, a process to produce high purity metallurgical and solar grade silicon from quartz; and PUREVAP NSiR, which is designed to transform silicon into spherical silicon nano powders and nanowires for use in lithium-ion batteries. It provides plasma torches and plasma torch systems used toreplace fossil fuel burners in industrial iron ore pelletization process; plasma arc waste destruction systems for waste destruction onboard ships; steam plasma arc refrigerant cracking systems for the destruction of certain refrigerants, including chlorofluorocarbons, hydrofluorocarbons, and hydrochlorofluorocarbons; plasma arc chemical warfare agent destruction systems, which are mobile platforms for the onsite destruction of chemical warfare agents; plasma resource recovery systems for land-based waste destruction and waste-to-energy applications; plasma torches for waste gasification and combustion; and plasma arc gasification and vitrification. In addition, it offers engineering and manufacturing expertise, and contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, additive manufacturing (including 3D printing), oil and gas, and environmental industries. Further, the company provides installation, commissioning, and start-up services. PyroGenesis Canada Inc. is headquartered in Montreal, Canada.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest LEXX, PYRGF, BGM, and ABVC Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest LEXX, PYRGF, BGM, and ABVC Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

LEXX, PYRGF, BGM, and ABVC Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

LEXX, PYRGF, BGM, and ABVC Company Descriptions

ABVC BioPharma NASDAQ:ABVC

BGM Group NASDAQ:BGM

Lexaria Bioscience NASDAQ:LEXX

PyroGenesis Canada NASDAQ:PYRGF

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest LEXX, PYRGF, BGM, and ABVC Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest LEXX, PYRGF, BGM, and ABVC Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

LEXX, PYRGF, BGM, and ABVC Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

LEXX, PYRGF, BGM, and ABVC Company Descriptions

ABVC BioPharma NASDAQ:ABVC

BGM Group NASDAQ:BGM

Lexaria Bioscience NASDAQ:LEXX

PyroGenesis Canada NASDAQ:PYRGF

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools